Director / PDMR dealings

RNS Number : 9237Y
Oxford Biomedica PLC
08 March 2012
 



OXFORD BIOMEDICA PLC

Director / PDMR dealings

 

Oxford, UK - 8 March 2012: Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, was informed on 7 March 2012 that two of its directors had acquired ordinary shares of 1p each ("Ordinary Shares") at a price of 3.022273p per Ordinary Share.

 

 

 

 

 

 

 

 

Interest after purchase

Director / PDMR

 

Title

 

Price

Number of Ordinary Shares acquired on 07 March 2012

 

Number of Ordinary Shares

 

% of total

issued share capital

Timothy Watts

 

CFO

 

3.022273p

1,000,000

 

1,000,000

 

0.1%

Paul Blake

 

NED

 

3.022273p

100,000

 

300,000

 

0.03%

 

The issued share capital of the Company is 944,875,557 1p ordinary shares.

 

For further information please contact:

 

 

For further information, please contact:


Oxford BioMedica plc:

John Dawson, Chief Executive Officer

Tim Watts, Chief Financial Officer

Lara Mott, Head of Corporate Communications

 

Tel: +44 (0)1865 783 000

 

Singer Capital Markets Limited:

Shaun Dobson/Claes Spång

 

Tel: +44 (0)20 3205 7500

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 

END

 
 

RDSLLFFTVIIDIIF